Global Urinary Incontinence Devices Market is Expected to Grow at a
[ad_1]
As per DelveInsight analysis, a growing prevalence of Urinary Incontinence cases, the development of novel devices, an aging population prone to urological conditions such as urinary tract infections, pelvic floor weakness, and conditions such as pregnancy, diabetes, menopause, and Parkinson’s disease are among the factors driving the Urinary Incontinence Devices market growth.
New York, USA, Feb. 15, 2022 (GLOBE NEWSWIRE) — Global Urinary Incontinence Devices Market is Expected to Grow at a CAGR of 6.32% During the Forecast Period (2021-26) | DelveInsight
As per DelveInsight analysis, a growing prevalence of Urinary Incontinence cases, the development of novel devices, an aging population prone to urological conditions such as urinary tract infections, pelvic floor weakness, and conditions such as pregnancy, diabetes, menopause, and Parkinson’s disease are among the factors driving the Urinary Incontinence Devices market growth.
DelveInsight’s Urinary Incontinence Devices Market Insights and Forecast report provides the current and forecast Urinary Incontinence Devices market, forthcoming developments in the devices, individual market shares, challenges, drivers, barriers, market trends, and key companies in the Urinary Incontinence Devices market.
Some of the Key Highlights from the Urinary Incontinence Devices Market Report
-
According to DelveInsight analysis, North America is expected to dominate the overall Urinary Incontinence Devices Market during the forecasted period.
-
Key players working proactively in the Urinary Incontinence Devices market include NeoTract, Inc., Cook Medical Inc., C.R. Bard Inc., Coloplast Corporation, Boston Scientific Corporation, Ethicon US, LLC, Medtronic PLC, A.M.I. Ltd., Teleflex Incorporated, Hollister Incorporated, ConvaTec Group PLC, Caldera Medical Inc., Prosurg, Inc., Laborie, Inc., Becton, Dickinson and Company, ZSI Surgical Implants, Atlantic Therapeutics, B. Braun Melsungen AG, Flexicare (Group) Limited, InControl Medical, and others.
-
As per DelveInsight estimates, the Global Urinary Incontinence Devices Market was valued at USD 2.8 billion in 2020 and is expected to grow at a CAGR of 6.32% from 2021 to 2026, reaching USD 4.03 billion by 2026.
-
According to findings from the feasibility phase of the SANS-UUI study, in September 2021 at the American Urological Association Annual Meeting, a novel, ultra-miniaturized sacral nerve modulation (SNM) system was shown to be both efficacious and safe in treating patients with UUI.
-
In April 2021, in Australia, Analytica Ltd. signed a joint venture agreement with Hebei Nacol Bio-Technology Co. Ltd. and Shijiazhuang Biosphere Pty Ltd., of Hebei Province, China, to manufacture and distribute its Pericoach device for Urinary Incontinence in China, Macau, Hong Kong, and Taiwan.
To pick on the latest highlights, get the snapshot of the key highlights entailed in the Urinary Incontinence Devices Market report.
Urinary Incontinence…
[ad_2]
Read More: Global Urinary Incontinence Devices Market is Expected to Grow at a